Advisor Net Financial, Inc Biomarin Pharmaceutical Inc Transaction History

Advisor Net Financial, Inc

$1.27 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$83.81 - $99.0 $32,350 - $38,214	-386 Reduced 97.47%	10 $0
Q4 2023 Jan 19, 2024	BUY	$76.22 - $98.51 $685 - $886	9 Added 2.33%	396 $38,000
Q3 2023 Oct 12, 2023	SELL	$85.07 - $94.48 $10,038 - $11,148	-118 Reduced 23.37%	387 $34,000
Q2 2023 Jul 14, 2023	SELL	$86.68 - $100.3 $184,455 - $213,438	-2,128 Reduced 80.82%	505 $43,000
Q1 2023 Apr 28, 2023	SELL	$87.74 - $117.27 $599,088 - $800,719	-6,828 Reduced 72.17%	2,633 $256,000
Q4 2022 Jan 13, 2023	BUY	$80.93 - $108.63 $2,104 - $2,824	26 Added 0.28%	9,461 $0
Q3 2022 Oct 04, 2022	BUY	$82.16 - $96.94 $10,270 - $12,117	125 Added 1.34%	9,435 $800,000
Q2 2022 Jul 07, 2022	BUY	$71.48 - $86.85 $25,732 - $31,265	360 Added 4.02%	9,310 $772,000
Q1 2022 Apr 14, 2022	BUY	$74.28 - $92.69 $105,329 - $131,434	1,418 Added 18.83%	8,950 $690,000
Q4 2021 Jan 19, 2022	BUY	$71.72 - $91.47 $54,363 - $69,334	758 Added 11.19%	7,532 $665,000
Q3 2021 Oct 15, 2021	BUY	$74.77 - $85.47 $53,610 - $61,281	717 Added 11.84%	6,774 $524,000
Q2 2021 Jul 06, 2021	BUY	$75.51 - $84.79 $24,993 - $28,065	331 Added 5.78%	6,057 $505,000
Q1 2021 Apr 14, 2021	BUY	$74.73 - $90.69 $67,630 - $82,074	905 Added 18.77%	5,726 $432,000
Q4 2020 Feb 04, 2021	BUY	$72.61 - $90.2 $8,350 - $10,373	115 Added 2.44%	4,821 $423,000
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $41,394 - $56,173	580 Added 14.06%	4,706 $398,000
Q2 2019 Jul 15, 2019	BUY	$80.35 - $93.9 $62,512 - $73,054	778 Added 23.24%	4,126 $353,000
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $11,619 - $13,609	-138 Reduced 3.96%	3,348 $297,000
Q4 2018 Feb 08, 2019	BUY	$80.14 - $106.07 $560 - $742	7 Added 0.2%	3,486 $297,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $15,027 - $16,915	-160 Reduced 4.4%	3,479 $337,000
Q4 2017 Feb 27, 2018	BUY	$80.76 - $95.13 $293,885 - $346,178	3,639	3,639 $324,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account